Johne and Frothingham (4) published their discovery of a pecuilar kind of "tuberculosis" in a cow in 1895. A few years later, Bang (1, 2) showed that the disease was not identical to tuberculosis and suggested the name paratuberculosis for it. The term Johne's disease frequently is used for the clinical condition, and the term Johne's bacillus is used for the organism. All attempts to culture the causative organism failed until Twort and Ingram (11,12) in 1910 found that the addition of some types of killed mycobacteria other than the pathogen to the culture medium provided an "essential substance," now known as mycobactin, which allowed the growth of the causative organism. (Mycobactin is the mycobacterial product regularly required as an iron-chelating agent for growth of Mycobacterium paratuberculosis.) They referred to the disease as pseudotuberculosis enteritis and to the causative organism as Myco bacterium enteritidis chronicae pseudotuberculosae bovis. Bergey et al. (3) were the first to propose a validly published name for this organism, Myco bacterium paratu berculosis, but no type strain was established. No culture of any of the strains on which the original description of this organism was based is known to be extant. Strain 18 has many antigenic properties s h ilar to those of newly isolated M. paratuberculosis strains, and it is used for vaccine and johnin (paratuberculin) production because it grows profusely and relatively rapidly as a surface pellicle on synthetic liquid medium without mycobactin. However, it is dissimilar to recently isolated M. paratuberculosis strains in those cultural characteristics as well as in being nonpathogenic for calves by either oral or intraarterial administration. Because strain 18 was isolated well after the original description of M . paratuberculosis was published, it cannot be considered for designation as the type strain of this organism.
At the request of the ATCC to establish a neotype, I submitted cultures of a newly isolated
